Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | 10.67%126.23M | 52.58%114.06M | 47.04%74.75M | 54.40%50.84M | 32.93M |
| Revenue from customers | 10.70%126.22M | 52.63%114.02M | 47.55%74.7M | 55.25%50.63M | --32.61M |
| Other cash income from operating activities | -93.96%2.25K | -21.22%37.22K | -77.24%47.25K | -33.67%207.62K | --313.01K |
| Cash paid | -9.98%-112.79M | -54.72%-102.55M | -61.35%-66.28M | -40.47%-41.08M | -29.25M |
| Payments to suppliers for goods and services | -9.98%-112.79M | -54.72%-102.55M | -61.35%-66.28M | -40.47%-41.08M | ---29.25M |
| Direct interest paid | -29.60%-1.82M | -51.59%-1.4M | -114.60%-924.45K | -225.96%-430.79K | ---132.16K |
| Direct interest received | -58.10%6.62K | 79.56%15.8K | 48.06%8.8K | 124.48%5.94K | --2.65K |
| Direct tax refund paid | -45.13%-4.02M | 1.39%-2.77M | -71.07%-2.81M | 2.47%-1.64M | ---1.69M |
| Operating cash flow | 3.51%7.6M | 54.88%7.34M | -38.31%4.74M | 312.46%7.69M | --1.86M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 52.85%-10.52M | -232.88%-22.31M | 36.59%-6.7M | -92.51%-10.57M | -5.49M |
| Net PPE purchase and sale | 56.32%-221.28K | -123.02%-506.6K | -97.27%-227.15K | -92.71%-115.15K | ---59.75K |
| Net intangibles purchas and sale | -52.07%-1.34M | 13.05%-881.05K | -32.40%-1.01M | -545.84%-765.32K | ---118.5K |
| Net business purchase and sale | 57.18%-8.96M | -283.07%-20.92M | 43.63%-5.46M | -82.39%-9.69M | ---5.31M |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 52.85%-10.52M | -232.88%-22.31M | 36.59%-6.7M | -92.51%-10.57M | ---5.49M |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -86.00%2.38M | 6,736.54%17.02M | -94.80%248.94K | 347.59%4.79M | 1.07M |
| Net issuance payments of debt | 20.27%7.24M | 69.63%6.02M | -48.10%3.55M | 203.80%6.84M | --2.25M |
| Net common stock issuance | -100.23%-36K | 41,872.08%15.81M | -104.43%-37.84K | --854.51K | ---- |
| Cash dividends paid | 0.38%-4.29M | -45.79%-4.3M | -12.08%-2.95M | -299.72%-2.63M | ---658.86K |
| Net other financing activities | 46.93%-532.32K | -62.37%-1M | -14.89%-617.78K | 48.45%-537.72K | ---1.04M |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -86.00%2.38M | 6,736.54%17.02M | -94.80%248.94K | 347.59%4.79M | --1.07M |
| Net cash flow | |||||
| Beginning cash position | 44.93%6.62M | -26.57%4.56M | 48.57%6.22M | -38.23%4.18M | --6.77M |
| Current changes in cash | -126.04%-534.76K | 220.01%2.05M | -189.77%-1.71M | 174.55%1.91M | ---2.56M |
| Effect of exchange rate changes | 486.83%8.78K | -103.85%-2.27K | -53.31%58.99K | 479.78%126.35K | ---33.27K |
| End cash Position | -7.95%6.09M | 44.93%6.62M | -26.57%4.56M | 48.57%6.22M | --4.18M |
| Free cash from | 1.42%6.04M | 70.11%5.96M | -48.56%3.5M | 310.29%6.81M | --1.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |